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Abstract
Nitrogen oxide (NOx) species represent ones of the most threatening air pollutants due 
to their prevalence and harmful impact on the environment and human health. The term 
NOx gathers mainly nitric oxide (NO) and nitrogen dioxide (NO
2
), mostly produced by 
anthropogenic activities such as transport and industries. Several cellular constituents 
were already described as NOx targets. These include membranes, proteins, respiratory 
chain enzymes, lipids, and DNA. Such damages lead to pathologies of lungs, cardio-
vascular system, and skin because these organs represent the first barrier toward the 
environment. On the other hand, NOx is also naturally synthetized by several organ-
isms, playing a mediator role in essential cellular functions. However, few data are yet 
available on NOx activity toward microorganisms. Here, we review data concerning the 
double face of NOx, including their use in the medical field against pathogens’ infections 
that highlight the versatility of these compounds.
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1. NOx species: the genesis of a major air pollutant
“Yet, pollution is the largest environmental cause of disease and death in the world today, 
responsible for an estimated 9 million premature deaths” stated The Lancet Commission in 
2017. This phenomenon represents an alarming threat for human health, as a major cause 
of respiratory and cardiovascular pathologies as well as infertility. Moreover, those atmo-
spheric pollutants have severe impacts on the environment and participate in climatic change, 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
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acidification, eutrophication, and ecosystem disturbances. Several international and national 
organizations (e.g. WHO, EEA, and INERIS) aim at reducing the global emission of pollut-
ants, thanks to environmental policies as Kyoto and Gothenburg protocols signed in 1997 and 
1999, respectively. After that, an encouraging decrease in air pollutants’ levels was measured 
between 2000 and 2015 [1].
Atmospheric pollutants can be classified into four families: classical, indoor, and organic or 
inorganic air pollutants. Among the classical ones, which are the principle in amount, sulfur 
dioxide (SO
2
), particle matter, ozone (O
3
), and nitrogen oxide (NOx) species are found [2]. 
The term NOx refers to a wide range of nitrogen-derived compounds, where nitric oxide 
(NO) and nitrogen dioxide (NO
2
) are predominant [3]. Those compounds can be naturally 
produced at low level by lightnings [4] and volcanic eruptions [5]. However, NOx is mainly 
generated by anthropogenic activity (e.g., road transport, energy production, industry, and 
agriculture) (Figure 1) [6].
Even if NO and NO
2
 represent the main species of NOx, nitrogen exists in several oxidation 
states in the environment, from N (−III) to N (+V). NO takes a central place in the series of 
reactive nitrogen species (RNS) [7]. Oxidation and reduction of NO result in the formation of 
several RNS, including nitrate or ammonium. NO
2
 is formed by the reaction of NO with O
2
 
and can be dimerized to give N
2
O
4
. The formed reactive species can, in turn, be involved in a 
wide range of reactions (Figure 2).
Nitrogen is an essential constituent of vital macromolecules (nucleic acids and proteins). This 
atom also constitutes the dinitrogen (N
2
) gas, usually abbreviated nitrogen. This gas repre-
sents 78% of atmospheric air and is continuously recycled in our environment. First, the atmo-
spheric nitrogen is fixed in the soil by prokaryotes to form ammonia (NH
3
), which could be 
taken up by plants. NH
3
 is then converted into ammonium (NH
4
+). Ammonium could be also 
Figure 1. NOx sources linked to anthropogenic activities (according to [1]).
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formed by mineralization of organic matter by decomposers (fungi, worms, and prokaryotes). 
The second part of the nitrogen cycle is the nitrification of ammonium by prokaryotes leading 
to nitrite (NO
2
−) formation, which is then further oxidized into nitrate (NO
3
−). Finally, nitrate 
could be assimilated by plants for their growth or converted into N
2
 by denitrifying bacteria 
(Figure 3).
Moreover, nitrogen is also the precursor of NOx. Indeed, NOx formation can be separated 
into four steps. First, NO is formed in the atmosphere in combination with nitrogen, resulting 
from the global biogeochemical nitrogen cycle, and oxygen, following combustion (natural or 
anthropic). Then, this highly reactive compound can be oxidized by oxygen (O
2
) to form NO
2
. 
Alternatively, nitrogen dioxide can also be directly formed through catalytic ammonia com-
bustion or nitrosyl chloride oxidation. Then, a temperature-dependent equilibrium is estab-
lishing between NO
2
 and its dimeric form, nitrogen tetroxide (N
2
O
4
−). Finally, a photochemical 
reaction between NO
2
 and hydroxyl radicals leads to the generation of ozone (O
3
−) (Figure 4).
Even if NO and NO
2
 are classified as RNS, their characteristics are very different suggest-
ing their diverse behavior and reactivity. For example, the solubility of NO is very low 
Figure 2. Redox relationships of NOx with other RNS. Black arrow: oxidation and reduction of NO; purple arrow: a 
wide range of reactions; roman numbers: oxidation state of the nitrogen atom; color gradient: reduction/oxidation state 
from (−III) to (V).
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(5.7 × 102 g/L), and NO
2
 is highly reactive in water resulting in the formation of HNO
2
 and 
HNO
3
 [8]. Moreover, the half-life time of those compounds highly differs because NO
2
 
half-life is around 35 h, whereas that of NO is almost impossible to determine because of 
its high reactivity [9]. The permeability of both compounds is also totally unrelated: NO 
has a lipophilic behavior with consequently a high-membrane permeability. This can be 
illustrated by the high-diffusion ability of NO toward the membrane. Conversely, the per-
meability coefficient of NO
2
 is estimated about 5 cm s−1 suggesting a lower diffusion power 
toward biological membranes [10]. In spite of these differences, the penetration of NO and 
NO
2
 inside cells and their high reactivity are at the origin of their pathogenic potential on 
human health, particularly when physiological elimination thresholds are exceeded. Since 
skin, respiratory tract, and lungs are the first barrier toward those gases, these organs 
are evidently the principle targets of these compounds and their derived species [11–13]. 
However, their diffusion deeper in the organism can lead afterward to other severe effects, 
for instance, on the cardiovascular and immune systems [12, 14]. Human health effects 
range from reversible (nausea, breathing difficulties, and asthma symptoms) to irreversible 
(cardiovascular defects, emphysema, and immunopathologies), including cancer induc-
tion in the worst cases (Figure 5) [15].
Figure 3. Nitrogen cycle at the interfaces among air, soil, and ecosystem. (1) Fixation of gaseous nitrogen by prokaryotes 
leading to ammonia (NH
3
) and ammonium (NH
4
+); (2) nitrification of NH
4
+ by prokaryotes resulting in nitrite formation 
(NO
2
−) subsequently oxidized into nitrate (NO
3
−); (3) denitrifying prokaryotes catalyzing the conversion of nitrate into 
gaseous N
2
.
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Thanks to epidemiological and clinical studies, thresholds of NO and NO
2
, whose chemical 
structure and conversion factors are represented Figure 6A, have been determined for dif-
ferent human health effects (Figure 6B and C, respectively). However, no guideline values 
are available for NO (Figure 6D) due to its complete and rapid reaction [16]. Thus, in order 
to limit health issues, international organizations, such as WHO, set up guidelines for atmo-
spheric NO
2
 limit value (Figure 6E).
NOx is then highly toxic compounds and has a myriad of deleterious impacts on the human 
physiology when the bearable thresholds are exceeded. However, NOx is also naturally pro-
duced by cellular processes in a wide range of living organisms. In this case, NOx can have 
totally different effects as discussed later.
Figure 4. Atmospheric genesis of NOx (adapted from [3]).
Figure 5. Representation of NOx targets and associated pathologies [11–15].
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2. The double face of NOx in the eukaryotic world
To better understand why NOx impact on so many organs, it is essential to focus on the units 
forming each part of our body: the eukaryotic cells themselves.
2.1. Exogenous NOx: a hostile intruder inside the eukaryotic cells
Much work was already performed on NOx targets at the cell scale. NO and NO
2
, thanks to 
their chemistry properties mentioned earlier, are highly diffusible through living membranes 
and exhibit a strong reactivity. It is easy to imagine the potential of such compounds. Since 
NO is highly reactive in lipophilic media, it can react inside the lipid bilayer, first protection 
of cells against the environment. Indeed, polyunsaturated fatty acids (PUFAs) are susceptible 
to NO in the presence of O
2
 and ONOO− [17]. The interaction of these toxic compounds with 
PUFA double bounds leads to the formation of nitrated FA. This process is considered as a 
protective strategy because it redirects O
2
− and ONOO−-mediated cytotoxic reactions to other 
oxidative pathways. Post-translational modification of several proteins is also observed in 
the presence of NOx and RNS. For example, tyrosine nitration on phenol residue mediated 
by peroxynitrite derived from OH and NO
2
 leads to 3-nitrotyrosine formation [18]. This mol-
ecule represents a useful biomarker of nitrosative stress in various pathologies such as ath-
erosclerosis [19]. Protein thiol residues are highly susceptible to NO and ONOO− leading to 
the formation of nitrosothiol (RS-NO) and nitrothiol (RS-ONO), respectively [20]. This revers-
ible modification modulates the activity of several proteins similar to phosphorylation. For 
example, S-nitrosylated cysteine thiol residue can be denitrosylated by S-nitrosoglutathione 
reductase or thioredoxin systems [21]. NO and other RNS can also nitrosylate [Fe─S] cluster 
of transition metal centers, which are essential for protein function. This modification can acti-
vate a wide range of enzymes such as the soluble guanylate cyclase (sGC) mentioned below 
Figure 6. Key features concerning NOx. (A) Lewis structure of NOx and conversion factors; (B) NO threshold (ppm) 
according to [9]; (C) NO
2
 threshold (ppm) according to [9]; (D) and (E) NO and NO
2
 guideline values, respectively, 
according to [1]. ppm, parts per million; ND, not determined.
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[22]. On the contrary, this reaction can also alter the protein function, for example, in the case 
of hemoglobin [23]. NO and other higher RNS products (ONOO− or NO
2
) are able to generate 
nitration, nitrosation, or deamination reactions on DNA bases leading to mutagenesis [24]. 
This phenomenon is enhanced by the inhibition of DNA repair triggered by NO [25]. More 
recently, a role of NO in epigenetic modification was suggested. To be more precise, this 
simple molecule seems to modulate histone acetylation and methylation through direct and 
indirect modulations of histone acetyltransferases and deacetylases, lysine demethylases, his-
tone methyltransferases activity, thus modifying the expression of several genes [26]. These 
pleiotropic activities of NO and derived compounds highlight here the necessity of fine regu-
lation pathways to prevent the development of several diseases.
2.2. Endogenous NO: an essential mediator of cellular signalization
Interestingly, NO can also be produced by several living organisms: plants, animals, and bac-
teria, thanks to a specific enzyme called nitric oxide synthase (NOS) [27, 28]. The large distribu-
tion of this enzyme through the different reigns emphasizes the importance of NO synthesis. 
Evolutionary studies highlight the necessity for the first living organisms during primitive era 
to eradicate toxic O
3
 present in the paleoatmosphere as a survival strategy. Indeed, the libera-
tion of gaseous NO in extracellular environment could have subsequently neutralized O
3
, thus 
limiting harmful oxidative reactions [29]. In eukaryotic cells, three isoforms of NOS have been 
described [30]. The neuronal nNOS (NOS-1) and the endothelial eNOS (NOS-3) are constitutively 
expressed but are only activated through calcium-dependent mechanisms. The third one is the 
inducible iNOS (NOS-2) expressed in macrophages following infection by pathogens, virus, or 
tumors. Contrary to NOS-1 and 3, NOS-2 is constitutively functional. Interestingly, these NOSs 
have high structural similarities with an oxygenase and a reductase domain (Figure 7) [27].
To be fully functional, NOS requires to associate with homodimers, and this form of NOS is 
crucial for the generation of NO [32]. When conditions are favorable (high level of l-arginine 
Figure 7. The structural similarities of NOS (adapted from [31]). BH
4
, tetrahydrobiopterin; l-arg, l-arginine-binding 
site; Heme Fe, iron protoporphyrin IX; CaM, calmodulin-binding site; FMN, flavin mononucleotide-binding site; 
FAD, flavin adenine dinucleotide-binding site; NADPH, nicotinamide adenine dinucleotide phosphate-binding site; *, 
palmitoylation and myristoylation of eNOS oxygenase domain.
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and cofactors like BH
4
), this enzyme catalyzes the conversion of l-arginine into l-citrulline 
using O
2
 and leading to NO formation with a ratio of 1:1 [33]. However, if these parameters 
are not available or if NOS remains monomeric, the enzyme only produces superoxide (O
2
−) 
[32]. Even if NOS isoforms catalyze the same reaction, their distribution is largely related to 
their respective functions.
2.2.1. The endothelial eNOS and vasodilatation
Endothelial nitric oxide synthase (eNOS) can be activated through calcium-dependent and 
independent pathways. On the one hand, through activation of specific receptors, such as 
acetylcholine muscarinic receptors, bradykinin receptors, and H1 histamine receptors, dis-
tributed in the endothelial cell membrane, agonists can trigger an increase in intracellu-
lar concentration of calcium (Ca2+) through the well-known polyphophoinosides pathway. 
Indeed, activation of those receptors stimulates membrane-associated PLCϒ and PI3K acti-
vation. This results into inositol trisphosphate (IP3) formation, which induces the release of 
intracellular calcium stock from endoplasmic reticulum [34]. Then, Ca2+ binds to calmodu-
lin (CaM), which could later fix on the calmodulin-binding domain of eNOS controlling 
its enzymatic activity. On the other hand, in response to hormones or growth factors act-
ing on their corresponding receptors, phosphate kinase A (PKA) or B (AKT) pathway can 
be induced mediating a phosphorylation cascade. The post-translational phosphorylation 
of eNOS on three specific sites (Ser617 and Ser1179 for AKt, Ser635 and Ser1177 for PKA) 
enhances the activity of the enzyme [35]. Moreover, the lipidation of eNOS (palmitoylation 
and myristoylation) could also enhance its activity [36]. This other post-translational modi-
fication promotes eNOS association with cell membrane and is stabilized by interaction with 
membrane chaperone proteins (caveolin-1 and HSP70/90). Both mechanisms are essential 
for linking upstream signal transduction pathway to eNOS activity in cells [37]. eNOS could 
then produce a large amount of NO, which latter diffuses freely inside smooth muscles. 
Herein, NO activates soluble guanylate cyclase (sGC) by reaction with the heme of the 
enzyme leading to the increase of cyclic guanosine monophosphate level (cGMP). cGMP 
subsequently activates phosphate kinase G (PKG) favoring a cytosolic Ca2+ reuptake into 
sarcoplasmic reticulum [38]. The decrease of intracellular level of Ca2+ leads to the relaxation 
of smooth muscle. Moreover, NO can inhibit caspases 3 and 8 and thus apoptosis through 
protein nitrosylation. NO released by endothelium is also reducing platelet aggregation and 
platelet or leukocyte adhesion (Figure 8) [39, 40].
Another source of NO inside endothelial cells was also described. Indeed, nitrite and 
nitrate reservoirs could be converted into NO by several enzymes such as cytochrome 
P450, hemoglobin, myoglobin, and others, under specific conditions [42]. However, 
several pathways could abolish NO production. Indeed, NO can be eliminated in com-
bination with reactive oxygen species (ROS). eNOS could be inactivated by several 
phosphatases. The removal of eNOS membrane sequestration by interaction between 
NOS-interacting protein (NOSIP) and NOS-traffic inducer (NOSTRIN) complex favors 
eNOS recycling [36]. Since NO plays a central role in this phenomenon, any abnormality 
altering its production leads to pathogenesis and vascular disorders such as atheroscle-
rosis and hypertension [43].
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2.2.2. The neuronal nNOS: a crucial element in neurotransmission
nNOS, also called NOS-1, was the first isoform discovered in the neuronal tissue. It should 
be distinguished between two subfamilies: nNOSα and nNOSμ, thanks to their locations and 
functions. Indeed, nNOSα is found in central nervous system and plays a major role in the 
neurotransmission at neuronal synapses, whereas nNOSμ is found in skeletal and cardiac 
muscle where NO controls muscle contractility and local blood flow.
2.2.2.1. nNOSα in the central nervous system
Glutamate is the major excitatory neurotransmitter in the brain. When deliver into the syn-
apse, this molecule is activating a specific receptor (NMDAR) located inside the postsynap-
tic membrane. Activated NMDAR thus allows the entry of calcium. Ca2+ are able to activate 
calmodulin by physical interaction [44]. Afterward calmodulin binds to nNOSα, which, in 
turn, is activated. Interestingly, nNOSα can indirectly interact with the NMDAR through its 
fixation on an adapter protein PSD95 by their PDZ interaction domain [45]. This allows the 
high speed of NO synthesis in response to NMDAR activation. Thereafter, NO can diffuse 
back to the presynaptic area leading to an increase glutamate release in the synaptic cleft and 
thus neurotransmission. CAPON, a chaperon protein of DexRas, was found altering the level 
Figure 8. Physiology of vasodilatation: implication of eNOS and NO (adapted from [41]). eNOS, endothelial nitric oxide 
synthase; ach, acetylcholine; BK, bradykinin; H, histamine; R, receptor; CaM, calmodulin; PLCϒ, phospholipase C ϒ; 
PI3K, phosphoinositide 3-kinase; PKA, phosphate kinase A; AKT, phosphate kinase B (PKB); sGC, soluble guanylate 
cyclase; cGMP, cyclic guanosine monophosphate; PKG, phosphate kinase G; A, protein complex of HSP70, HSP90, and 
caveolin-1; NOSIP, NOS-interacting protein; NOSTRIN, NOS traffic inducer.
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of nNOSα present at the membrane [46]. Indeed, CAPON competes with the PDZ domain 
of nNOSα and thus promotes its detachment from the NMDAR-PSD95 complex. nNOSα 
interaction with CAPON-DexRas complex allows the activation of DexRas, a small protein 
G, through s-nitrosylation on its thiol residue [47]. Then, DexRas activates the MAPK cascade 
and the transcription of several genes [47]. Several shutdown systems are available to limit 
this process, which could dramatically affect the brain physiology by synapses hyperactiva-
tion. Indeed, kinases, such as PKC or PKII, can phosphorylate nNOSα leading to its loss of 
activity [48]. nNOSα can also be sequestrated by two membrane proteins (caveolins 1 and 3) 
preventing its interaction with calmodulin (Figure 9).
As mentioned above, any disorder affecting NO synthesis can lead to dramatic consequences 
in the brain. Indeed, a lack of NO could impair the neurotransmission and hence the neuronal 
plasticity, such as long-term potentiation (LTP) in the hippocampus or long-term depression 
(LTD) in the cerebellum [50]. NO ensures also the correct irrigation of brain by its vasodilator 
effect on peripheral blood vessel. The synthesis of NO can be altered by a deficiency or a loss of 
activity of nNOS. Other regulatory elements, such as the decrease of l-arginine precursor avail-
ability or cofactors crucial for the catalytic activity of NOS, contribute also to nNOS inactivation. 
Conversely, in some several brain pathologies (ischemia, strokes, neurodegenerative disorders 
including Parkinson’s and Huntington’s diseases, and amyotrophic lateral sclerosis), a large 
amount of NO is produced [51]. It is hypothesized that NO or derived nitrogen species interact 
with various proteins inducing several toxic effects. Thus, pharmacological regulation of NO 
synthesis offers important strategies for the treatment of neurodegenerative and muscle diseases.
2.2.2.2. nNOSμ in peripheral neurotransmission
On the other hand, nNOSμ is located in skeletal and cardiac muscle where NO controls mus-
cle contractility and local blood flow essential to support muscular effort. When the excitatory 
neurotransmitter acetylcholine (Ach) is released at the neuromuscular junction, it is activating 
specific acetylcholine nicotinic receptors present on muscle cells [52]. Activation of these recep-
tors allows the release in the cell sarcoplasm of calcium from exogenous and/or endogenous 
Figure 9. The neurotransmission mediated by NOSα in central nervous system (CNS) (adapted from [49]). Glu, 
glutamate neurotransmitter; NMDAR, N-methyl d-aspartate type-glutamate receptor; A, PSD95 protein adapter 
between nNOSα and NMDAR; CaM, calmodulin; PKC, phosphate kinase C; PKII, Ca2+/CaM-dependent protein kinase 
II; CaN, calcineurin; CAPON, C-terminal PDZ domain ligand of neuronal nitric oxide synthase; MAPK, mitogen-
activated protein kinase.
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sources. This process is also enhanced by the activation of a voltage-dependent Ca2+ channel 
(CaCn) [53]. The increase of Ca2+ from exogenous origin activates ryanodine receptor present 
on the sarcoplasmic reticulum, which, in turn, delivers a large amount of Ca2+. When the Ca2+ 
threshold is reached, it is binding on the calmodulin protein. Calmodulin can then interact 
with the nNOSμ to activate the generation of NO. Interestingly, nNOSμ interacts through 
its PDZ domain with adapter proteins (syntrophins) linked to a membrane protein complex 
called dystrophin [54]. Produced NO could then diffuse back to the motor neuron to enhance 
the liberation of neurotransmitters or the vasodilatation of blood vessels, thus increasing the 
local blood flow to support muscle needs during contraction efforts (Figure 10) [55].
NO synthesis is also well regulated by calpain (Calp). Indeed, this protein interacts with the 
PDZ domain nNOSμ provoking its detachment from the dystrophin/syntrophin membrane 
complex [56]. Interestingly, in muscular Duchenne dystrophy, the damages caused by dystro-
phin absence are enhanced in case of simultaneous lack of nNOSμ [57]. Thus, NO donors may 
offer a potential avenue for therapy.
2.2.3. The inducible iNOS and the innate immunity
NO also takes an important part in innate immunity. Indeed, NO and derived compounds 
are cytotoxic weapon against tumor cells, microorganisms, and viruses [58]. NO is generated 
by inducible nitric oxide synthases (iNOS and NOS2) within macrophages. However, more 
recently, studies have shown that this enzyme is also expressed in other cell line (vascular endo-
thelial cells, hepatocytes, pulmonary, and colonic epithelial cells) [59]. Unlike nNOS or eNOS, 
its expression is stimulated by several pathways after activation of specific receptors by endo-
toxins (LPS) or cytokines (TNFα, IFNϒ, and IL1β). Briefly, the LPS endotoxins are carried by 
an LPS-binding (LPB) protein to its specific Toll-like receptor 4 (TLR4). Then, the transduction 
Figure 10. nNOSμ activity at the neuromuscular junction (adapted from [49]). Ach, acetylcholine; CaCn, voltage-
dependent Ca2+ channel; AchR, acetylcholine receptor; yellow lightning symbols, membrane depolarization; Ca2+, 
calcium; RyR, ryanodine receptor; l-cit, l-citrulline; l-arg, l-arginine; CaM, calmodulin; A, syntrophin α1, β1 and β2 
adapter between dystrophin and nNOSμ; Calp, calpain.
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of the signal leads to the transcription of NF-κB [60]. This transcription factor is essential for 
the expression of iNOS gene. On the other hand, cytokines produced by infected cells activate 
pathways responsible for the expression of several transcription factors (NF-κB, AP1, and IRF1) 
also involved in the transcription of iNOS [61]. Both pathways are necessary to fully upregulate 
iNOS expression. Moreover, iNOS is constitutively active and exhibits a high affinity for calcium 
explaining its Ca2+-independent activity. iNOS produces a large amount of NO until substrate 
depletion [62]. Then, NO acts directly or through derived compounds (mostly ONOO− and NO
2
) 
generated through the reaction of NO with ROS formed by NADPH oxidase. These molecules 
can be generated inside (phagosome) or outside the cells. Altogether, NO and derivatives could 
act in synergy on several components within the targeted hostile elements such as proteins (thi-
ols, metal centers, and tyrosine residues), nucleic acids, and lipids [63, 64]. Altogether, these 
modifications lead to irreversible damages impairing cellular metabolism and ultimately inhibit 
growth and replication mechanisms and even cell death (Figure 11).
After infection, NO generation is abolished by neutralization of iNOS activity. Indeed, iNOS 
undergoes a posttranslational modification called polyubiquitination leading to its proteasomal 
degradation. Physiological aggresome, an alternative pathway for protein degradation, is also 
involved in iNOS inactivation [66]. The degradation of NO can also be modulated by its own 
interaction with ROS. The depletion of l-arginine precursor also shuts down iNOS activity.
Overexpression of iNOS is observed during chronic infection leading to an excessive level 
of NO and RNS. This phenomenon can impair the host physiology because these high reac-
tive compounds represent mutagenic sources. Thus, the NO balance is a crucial point to 
Figure 11. Implication of iNOS in the innate immunity (adapted from [65]). IFNϒ, interferon ϒ; IFNR1/2, IFNϒ receptors 
1 and 2; JAK, Janus kinase; STAT, signal transducer and activator of transcription; IRF1, interferon response factor 1; 
IL1β, interleukin 1β; IL1R, IL1β receptor; MAPK, mitogen-activated protein kinase; JNK, C-Jun N-terminal kinase; 
ERK, extracellular signal-regulated kinase; AP1, activator protein 1; TNF-α, tumor necrosis factor α; TNFR, tumor 
necrosis factor receptor; NF-κB, nuclear factor κB; TLR4, Toll-like receptor 4; CD14, cluster of differentiation 14; LPS, 
lipopolysaccharide; LPB, LPS-binding protein; ROS, reactive oxygen species.
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control in order to limit its tumorigenic potential. The development of iNOS inhibitors and 
NO-releasing agents offers interesting therapeutic strategies to struggle against cancer and 
microbial infections.
3. NOx versus prokaryote: “Catch me if you can”
3.1. NOx at the center of prokaryotic life, virulence, and death
Several environmental, commensal, and pathogenic prokaryotes possess an arsenal of pro-
teins dedicated to the nitrogen metabolism under anaerobic conditions [67]. Indeed, an enzy-
matic chain is involved in the denitrification pathway responsible for the production of NO 
through nitrite reductase (NIR) as an intermediate. The outcome of this mechanism is the 
formation of dinitrogen (N
2
). This process is crucial for the growth of bacteria in the absence 
of oxygen because it is coupled with ATP generation (Figure 12).
Interestingly, a shortened NOS-like protein called bNOS was discovered in Gram-positive 
bacteria [28]. This enzyme is deprived of the classical reductase domain already described in 
other NOS isoforms. However, bNOS is able to recruit other proteins exhibiting a reductase 
catalytic activity [69]. Similar to mammalian isoforms, bNOS catalyzes the production of NO 
using l-arginine precursor. However, NOx is key elements in the innate immunity to avoid 
infection. Indeed, similar to eukaryotic cells, prokaryotes are also sensitive to NOx activity. 
Thence, such compounds could alter DNA, proteins, and metal centers leading to severe alter-
ations of bacterial growth and replication.
As previously described, NO could be endogenously produced by bacteria but is also a pow-
erful exogenous antimicrobial agent. This highlights the requirement of systems to manage a 
bearable threshold of NOx within the cell. First, bacteria have developed NO sensing system 
Figure 12. Bacterial nitrogen cycle (adapted from [68]). NO
3
−, nitrate; NO
2
−, nitrite; NO, nitric oxide; N
2
O, nitrous oxide; 
N
2
, dinitrogen; NH
2
OH, hydroxylamine; NH
4
+, ammonia; NAR/NAP, nitrate reductase; NIR, nitrite reductase; NOR, 
nitric oxide reductase; N
2
OR, nitrous oxide reductase.
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through non-heme iron cluster conjugated with a wide range of detoxification mechanisms. 
Several pathways involving reaction of NO with non-heme iron cluster were described, mainly 
in Escherichia coli [70]. Indeed, NO can lead to a raise of the repression of sulfur assimilation 
operon (suf) exerted by ferric uptake regulator protein (Fur). This reaction is mediated by Fur 
nitrosylation through NO-derived S-nitrosoglutathione (GSNO). Suf products are required 
for the biogenesis of the [Fe─S] cluster, which, in turn, gives a lure to get rid of NOx collat-
eral damages. The flavohemoglobin (hmpA) is another response against the nitrosative stress. 
This enzyme catalyzes the conversion of NO into nitrous oxide (N
2
O) under anaerobic condi-
tions. Interestingly, in the presence of NO, the S-nitrosylation of cysteine residues on MetR 
and FNR inactivates both the proteins. Thus, the repression exerted by MetR and the fumarate 
and nitrate reductase regulatory protein (FNR) is raised by hmpA allowing its transcription. 
Furthermore, NO-responsive transcriptional factor (NorR) is directly activated by NO and 
enhances the expression of NorVW protein catalyzing the reduction of NO into N
2
O. Redox-
sensitive cysteines also take part in the NO-sensing systems. Indeed, NO-activated superox-
ide regulon (SoxR) protein leads to the transcription increase of superoxide dismutase (sodA) 
removing O
2
− that may react with NO to form NO
2
 and ONOO− [71]. Similar to SoxR, peroxide 
regulon (OxyR) protein is activated by S-nitrosylation. This protein induces gene expression 
for protective products against nitrosative stress at least by limiting the S-nitrosylation [72]. 
For example, the expression of catalase KatA, which could buffer free NO, is activated by 
OxyR [73]. Altogether, these sensing systems lead to the efficient detoxification by generation 
of less toxic compounds or scavenger molecules.
Moreover, bacteria also develop repairing system of DNA and [Fe─S] cluster damages related 
to nitrosative stress. Similar to eukaryotic cells, five DNA repair pathways are available in 
prokaryotes. Among them, the base excision repair (BER), to repair deaminated base, and 
the nucleotide excision repair (NER), to remove cross-linking in DNA, are predominant [74]. 
Concerning the [Fe─S] cluster repair, the iron sulfur cluster S protein (IscS), a cysteine desul-
furase, can denytrosylate these protein clusters in the presence of l-cysteine [75]. Moreover, 
Isc regulator (IscR) protein is able to sense nitrosylated [Fe─S] cluster and thus enhances the 
formation and/or repair of [Fe─S] cluster [76, 77].
NO could also alter tricarboxylic acid (TCA) metabolic pathway and bacterial respiration 
through reaction with aconitase and cytochromes of the electron transfer chain, respectively 
[78]. However, these mechanisms are crucial for the generation of ATP and hence the ener-
getic needs of bacteria [79]. To counteract the inefficiency of this enzyme, some bacteria are 
able to reprogram their metabolism. For example, Pseudomonas spp. uses the citrate lyase, 
phosphoenolpyruvate carboxylase, and pyruvate phosphate dikinase to convert citrate into 
pyruvate and ATP [80].
In nonlethal concentrations, NO interplays a signaling role in bacteria through several proteins 
possessing heme-nitric oxide/oxygen-binding domain and is referred under the name H-NOX 
proteins. H-NOX exhibits a highly conserved domain among bacteria and also shared in mam-
mals (sGC) [81]. All H-NOX are histidine-ligated protoporphyrin IX hemoprotein able to fix 
NO on its ferrous iron. The H-NOX-encoding genes are found in operons with diverse bacte-
rial signaling genes [82], whose majority is now divided in two classes: containing (i) histidine 
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kinase (HK) or (ii) diguanylate cyclase (DGCs) and phosphodiesterase (PDE). H-NOX could 
modify the function of proteins implicated in virulence such as biofilm formation and motility 
or even quorum sensing [83]. For example, H-NOX alters the function of diguanylate cyclase 
and enhances the phosphodiesterase activity. Altogether, this leads to the biofilm dispersion 
through the decrease of c-di-GMP, an essential mediator in this process. On the contrary, a 
more sophisticated system relative to histidine kinase (HnoK) activity leads to the accumula-
tion of c-di-GMP in response to NO favoring the biofilm adhesion and formation. Another 
important virulence trait could be also modulated by H-NOX as in Vibrio species a cross-talk 
with QS seems to exist. However, a few studies are yet available.
More recently, an antibiotic resistance modulation was promoted by a bacterial NO
2
 gaseous 
exposure. Indeed, an upregulation in expression of MexEF-OprN efflux pump was observed 
coupled with an increase in related antibiotic resistance [84]. The link between NO
2
 and this 
efflux pump is yet not established, but the authors suggest here a potential role of this protein 
in the releasing of NOx outside the cells. Previous studies also highlight a correlation between 
NO endogenously generated by bNOS and increase aminoglycoside resistance [85]. NO and 
NO
2
 could directly interact with antibiotic leading to a less toxic compound and exerted a 
repression of bacterial respiration preventing drug uptake.
To resume, bacteria are able to produce NO and RNS. Following endogenous burst or exog-
enous aggression (pollution, inflammation reactions), a physiological threshold is exceeded. 
However, bacteria developed an ingenious system to counteract the potential effects of NO 
and derived products. Various interconnected signaling pathways are implicated in this phe-
nomenon: (i) NO detection, (ii) detoxification, (iii) repairing mechanisms, and (iv) metabolic 
reprogramming. Finally, these fundamental modifications modulate bacterial community 
behavior (QS) and virulence traits, such as biofilm and antibiotic resistance. This last point is 
particularly attractive in medicine. Indeed, the emergence of several antibiotic multiresistant 
pathogens represents a big threat for human that brings us to the last question of this review: 
“Does NOx therapy represent the new trends in human health care?”
3.2. The novel therapeutic strategies mediated by NOx
A lot of therapeutic strategies exploiting NOx-mediated pathways has recently emerged, par-
ticularly to treat cancer. Here we propose to classify them in three families: (i) NO-donor 
compounds, materials, or nanoparticles; (ii) modulators of NOS activity; and (iii) last but not 
least, generators of gaseous NO.
The first family NO donors consist of NO-chelating compounds that can release NO under 
specific conditions within the organism after administration. As shown below, several NO 
donors have been developed during the last decade. Their global—direct or not—anticancer 
effects have been exploited in the case of various carcinoma (Table 1).
For further information, we strongly recommend to read the review of Huang et al. [86]. 
Another extension of the use of NO-donor compounds is their graft on material and nanopar-
ticles. Indeed, prosthetic biomaterials used in medical devices were modified through cova-
lent or noncovalent binding of two NO donors (diazeniumdiolates and S-nitrosothiols). 
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Several clinical trials have shown their usefulness in the context of preventing thrombus 
formation [87]. NO-donating nanoparticle systems represent a new promising tumoricidal 
agents, thanks to their unique properties: (i) strengthening NO-donor stability, (ii) loading a 
large amount of NO, and (iii) possibility to trigger NO releasing [88].
The modulation of NOS activity is another interesting strategy. In some pathologies inducing 
exacerbating inflammation (sepsis), a localized “nitrosative burst” occurs, and inhibition of 
NOS function is a crucial element. Thus, several l-arginine precursor analogs (Nω-substituted 
l-arginine) were developed and tested. However, since l-arginine is the common point 
between all NOS isoforms, these analogs represent nonselective drugs. Moreover, such ther-
apy did not reach clinical studies on human stage despite its effects on canine vascular tone 
[89]. Thus, investigation on a more selective inhibition of iNOS, crucial for inflammation, 
was conducted through transgenic animals. Unfortunately, iNOS knockout mice exhibit an 
increase in mortality following polymicrobial sepsis [90]. More recently, researcher focused 
on increasing NO delivery within cancers. Thus, thanks to technical progress and scientific 
knowledge updating, iNOS-based suicide gene therapy was investigated through viral vec-
tor use. This treatment exhibits promising tumoricidal effects and appears interesting for its 
specific and localized iNOS expression on animal models [91].
The third strategy is the direct gaseous delivery of NO in the treatment of various infection 
diseases related to antibiotic resistant bacteria. Ghaffari et al. provided a considerable work 
on this topic. First, they developed an ingenious delivery system usefulness for the monitor-
ing of gNO effects on microorganisms (bacteria and fungi) and eukaryotic cells [92]. Then, 
they reported an effective concentration of gNO up to 200 ppm in continuous 4 h delivery 
exhibiting bacteriostatic effects on a representative group of microorganisms (Staphylococcus 
aureus, Pseudomonas aeruginosa, E. coli, Candida albicans, and Group B Streptococcus). Moreover, 
no toxic effects were observed on representative mammalian cell lines (dermal fibroblasts) of 
wound-healing pathology such as leg ulcer or burn injuries [93]. Thus, these promising results 
placed gNO as a potential topical antibiotic agent [94]. Later, they also investigated the poten-
tial use of inhaled gNO in the treatment of pathogenic infection in the case of cystic fibrosis. 
Indeed, this pathology is a threatening pulmonary disease where microbial infection could 
be lethal. However, a continuous exposure of gNO at such concentration can lead to severe 
Table 1. The different classes of NO donor (adapted from [86]).
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impact on the human health, particularly through methemoglobinemia. This phenomenon 
occurs when hemoglobin losses its vital function of oxygen carrier following the saturation of 
its iron heme with NO. Thus, an intermittent high-dose short-duration exposure was tested 
to determine the dose/duration most effective treatment. An adapted lung mammalian model 
was also used (macrophages and monocytes and pulmonary epithelial cells) to appreciate the 
potential effects of this cure on human health [95]. This study reached phase I clinical studies 
using a promising NO treatment at 160 ppm for 30 min three times daily for two periods of 
5 days [96]. However, as reviewed by Petit et al., it is important to keep in mind that “admin-
istration of inhaled NO is associated with and unavoidable codelivery of NO
2
,” thanks to the 
spontaneous high reactivity of NO with O
2
 [97]. They also reported that the higher NO doses 
are used, the faster is the formation rate of NO
2
. In contrast, a direct gaseous NO
2
 exposure 
could also be benefit in the struggle against undesirable microorganism because it seems to 
impact their metabolism, social behavior, and growth [84]. Moreover, a continuous high-dose 
NO
2
 exposure seems to lead in membrane alteration through an increased permeability [98].
4. Conclusion
In summary, this review of the literature shows that NOx is ubiquitous and essential in our 
lives. We are exposed to these compounds through environmental contaminations, but they 
also result from physiological processes, infections, diseases, or even drugs. NO and deriva-
tives are implicated in a large diversity of vital functions including brain functions; motricity; 
cardiac, vascular, and pulmonary functions; and immunity. For these reasons, NOx is key 
molecules of major biochemical interest. As all active substances, NOx can exert both benefi-
cial and adverse effects with regard to the exposition dose. The physiological adaptation to 
NOx results from a fine-tuned equilibrium where detoxification plays crucial roles. Myriad 
of finely regulated processes has emerged in response to nitrosative stress. Our knowledge 
still remains incomplete, and future studies are necessary to finely precise the synergy of 
each NOx implemented in nitrosative stress, especially when they are presented in gaseous 
phase that remains less explored. However, in spite of all previously described mechanisms 
to counteract the nitrosative stress, abnormal NOx thresholds could trigger a wide range of 
pathologies and even death. These antagonists, positive and negative effects, of NOx are actu-
ally intriguing. So, many researches are now focusing on NOx producing pathways to find 
the most effective treatments and drugs. More investigations are still needed to better under-
stand the real potential of NOx as antitumor, antibacterial agents, and their safe clinical use.
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